These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Recognition of Plasmodium falciparum mature gametocyte-infected erythrocytes by antibodies of semi-immune adults and malaria-exposed children from Gabon. Gebru T; Ajua A; Theisen M; Esen M; Ngoa UA; Issifou S; Adegnika AA; Kremsner PG; Mordmüller B; Held J Malar J; 2017 Apr; 16(1):176. PubMed ID: 28446190 [TBL] [Abstract][Full Text] [Related]
31. Research note: HLA degenerate T-cell epitopes from Plasmodium falciparum liver stage-specific antigen 1 (LSA-1) are highly conserved in isolates from geographically distinct areas. Ravichandran M; Doolan DL; Cox-Singh J; Hoffman SL; Singh B Parasite Immunol; 2000 Sep; 22(9):469-73. PubMed ID: 10972854 [TBL] [Abstract][Full Text] [Related]
32. Analysis of the immune response of a new malaria vaccine based on the modification of cryptic epitopes. Shen Y; Wang J; Huang Y; Liang J; Liu X; Wu D; Jiang H; Zhao Y; Li Y Parasitol Res; 2016 May; 115(5):1907-13. PubMed ID: 26833322 [TBL] [Abstract][Full Text] [Related]
33. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Polley SD; Conway DJ; Cavanagh DR; McBride JS; Lowe BS; Williams TN; Mwangi TW; Marsh K Vaccine; 2006 May; 24(19):4233-46. PubMed ID: 16111789 [TBL] [Abstract][Full Text] [Related]
34. Efficacy model for antibody-mediated pre-erythrocytic malaria vaccines. White MT; Griffin JT; Riley EM; Drakeley CJ; Moorman AM; Sumba PO; Kazura JW; Ghani AC; John CC Proc Biol Sci; 2011 May; 278(1710):1298-305. PubMed ID: 20943696 [TBL] [Abstract][Full Text] [Related]